(Q39556871)

13 September 2017

title

Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination (English)

1 reference

13 September 2017

1 reference

Schröder FH

1

1 reference

13 September 2017

Roobol-Bouts M

2

1 reference

13 September 2017

Vis AN

3

1 reference

13 September 2017

van der Kwast T

4

1 reference

13 September 2017

Kranse R

5

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

13 September 2017

1 reference

13 September 2017

volume

57

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

83-90

1 reference

Advanced prostate cancer: course, care, and cost implications

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900863-3

7 January 2021

Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900863-3

7 January 2021

Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region).

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900863-3

7 January 2021

Prospective evaluation plan for randomised trials of prostate cancer screening. The International Prostate Cancer Screening Trial Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900863-3

7 January 2021

European randomized study of screening for prostate cancer--the Rotterdam pilot studies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900863-3

7 January 2021

Rationale for randomised trials of prostate cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900863-3

7 January 2021

Making the most out of six systematic sextant biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900863-3

7 January 2021

Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900863-3

7 January 2021

Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900863-3

7 January 2021

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900863-3

7 January 2021

The Nature of Prostate Cancer Detected Through Prostate Specific Antigen Based Screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900863-3

7 January 2021

Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900863-3

7 January 2021

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900863-3

7 January 2021

The Pathological Features and Prognosis of Prostate Cancer Detectable With Current Diagnostic Tests

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900863-3

7 January 2021

10.1016/S0090-4295(00)00863-3

Identifiers

DOI

1 reference

13 September 2017

1 reference